Alpine Global Management LLC Has $1.76 Million Stock Holdings in Liquidia Co. (NASDAQ:LQDA)

Alpine Global Management LLC increased its position in shares of Liquidia Co. (NASDAQ:LQDA - Free Report) by 50.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 150,000 shares of the company's stock after acquiring an additional 50,000 shares during the period. Alpine Global Management LLC owned approximately 0.18% of Liquidia worth $1,764,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the business. Vanguard Group Inc. raised its holdings in Liquidia by 3.4% during the 4th quarter. Vanguard Group Inc. now owns 3,557,296 shares of the company's stock worth $41,834,000 after buying an additional 115,367 shares during the period. LM Advisors LLC acquired a new stake in shares of Liquidia during the fourth quarter valued at approximately $25,948,000. Geode Capital Management LLC lifted its position in shares of Liquidia by 8.2% in the 4th quarter. Geode Capital Management LLC now owns 1,339,254 shares of the company's stock valued at $15,753,000 after acquiring an additional 101,597 shares in the last quarter. Invesco Ltd. boosted its stake in Liquidia by 2,675.0% in the 4th quarter. Invesco Ltd. now owns 700,171 shares of the company's stock worth $8,234,000 after purchasing an additional 674,940 shares during the period. Finally, Eversept Partners LP grew its position in Liquidia by 314.1% during the 4th quarter. Eversept Partners LP now owns 571,305 shares of the company's stock worth $6,719,000 after purchasing an additional 433,356 shares in the last quarter. 64.54% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Liquidia

In other news, CEO Roger Jeffs sold 14,130 shares of the company's stock in a transaction dated Monday, April 14th. The shares were sold at an average price of $13.57, for a total value of $191,744.10. Following the sale, the chief executive officer now owns 1,006,420 shares of the company's stock, valued at approximately $13,657,119.40. This represents a 1.38 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Jason Adair sold 1,856 shares of Liquidia stock in a transaction dated Monday, April 14th. The shares were sold at an average price of $13.57, for a total transaction of $25,185.92. Following the transaction, the insider now directly owns 184,304 shares of the company's stock, valued at $2,501,005.28. This represents a 1.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 33,128 shares of company stock valued at $450,072. 30.10% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

LQDA has been the subject of a number of research analyst reports. HC Wainwright restated a "buy" rating and issued a $29.00 target price on shares of Liquidia in a report on Thursday, March 20th. Scotiabank reissued an "outperform" rating on shares of Liquidia in a research note on Thursday, March 20th. Finally, Needham & Company LLC reaffirmed a "buy" rating and set a $25.00 target price on shares of Liquidia in a research note on Thursday, April 10th. One research analyst has rated the stock with a hold rating, six have issued a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Buy" and an average target price of $26.63.

Liquidia Stock Up 0.6 %

NASDAQ LQDA traded up $0.09 during trading on Friday, hitting $14.12. The company's stock had a trading volume of 584,669 shares, compared to its average volume of 959,816. Liquidia Co. has a 52 week low of $8.26 and a 52 week high of $16.81. The firm has a market cap of $1.20 billion, a P/E ratio of -8.66 and a beta of 0.23. The firm has a 50 day moving average price of $14.44 and a 200 day moving average price of $12.87.

Liquidia (NASDAQ:LQDA - Get Free Report) last released its quarterly earnings data on Wednesday, March 19th. The company reported ($0.46) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.38) by ($0.08). Liquidia had a negative net margin of 765.38% and a negative return on equity of 163.21%. The firm had revenue of $2.92 million for the quarter, compared to the consensus estimate of $4.60 million. On average, equities analysts expect that Liquidia Co. will post -1.51 earnings per share for the current year.

About Liquidia

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).